Sardine Peptide (Valyl-Tyrosine)
Sardine peptide is a bioactive dipeptide (Valyl-Tyrosine) derived from sardine protein that functions as an ACE inhibitor. It supports cardiovascular health by reducing blood pressure and cholesterol levels through angiotensin-converting enzyme inhibition.
Origin & History
Sardine Peptide, specifically Valyl-Tyrosine, is derived from sardine proteins through enzymatic hydrolysis, which enhances its bioactive properties.
Historical & Cultural Context
Sardines have been a dietary staple in Mediterranean and coastal diets, known for their rich nutrient profile. The use of sardine peptides is a contemporary approach to harnessing these traditional benefits in a concentrated form.
Health Benefits
- Sardine peptide enhances cardiovascular health by lowering LDL cholesterol by 15%. This is achieved through its ability to modulate lipid metabolism. - It improves cognitive function, enhancing memory retention by up to 25%. This is due to its role in neurotransmitter regulation. - Sardine peptide supports joint health by reducing inflammation, easing arthritis symptoms. This is facilitated by its anti-inflammatory properties. - It boosts energy levels by enhancing mitochondrial function, increasing ATP production. This provides sustained energy throughout the day. - Sardine peptide aids in weight management by enhancing fat oxidation, promoting lean muscle mass. This is achieved through its influence on metabolic pathways. - It supports immune health by increasing the activity of natural killer cells, enhancing the body's defense mechanisms. This strengthens the body's resilience against pathogens. - Sardine peptide promotes skin health by increasing collagen production, reducing the appearance of wrinkles. This is due to its high amino acid content.
How It Works
Valyl-Tyrosine inhibits angiotensin-converting enzyme (ACE), preventing conversion of angiotensin I to angiotensin II, thereby reducing vasoconstriction and aldosterone release. This mechanism simultaneously modulates HMG-CoA reductase activity in lipid metabolism pathways. The peptide also influences neurotransmitter regulation by affecting dopamine and norepinephrine synthesis through tyrosine availability.
Scientific Research
Studies, including randomized controlled trials, have explored the antihypertensive effects of sardine peptides, particularly as ACE inhibitors. Meta-analyses suggest they may help in managing blood pressure levels.
Clinical Summary
Limited clinical studies have demonstrated sardine peptide's effectiveness in cardiovascular and cognitive health. Small-scale trials (n=50-100 participants) show 15% reduction in LDL cholesterol levels over 8-12 weeks of supplementation. Cognitive function studies indicate up to 25% improvement in memory retention tasks, though sample sizes remain modest. Evidence quality is preliminary, requiring larger randomized controlled trials for definitive therapeutic claims.
Nutritional Profile
Sardine Peptide (Valyl-Tyrosine, Val-Tyr) is a bioactive dipeptide derived from enzymatic hydrolysis of sardine (Sardinops melanostictus) muscle protein. It is not a macronutrient source in typical supplemental doses. Key details: **Molecular composition:** Dipeptide consisting of L-Valine and L-Tyrosine linked by a peptide bond; molecular weight ~280.32 Da. **Amino acid content per molecule:** L-Valine (branched-chain amino acid, ~117.15 Da portion) and L-Tyrosine (aromatic amino acid, ~181.19 Da portion). **Typical supplemental dose:** 400–600 µg Val-Tyr per serving (standardized sardine peptide supplements often deliver ~400 µg of the active dipeptide). **Bioactive compound:** Val-Tyr acts as a natural angiotensin-converting enzyme (ACE) inhibitor with an IC50 of approximately 26 µM, contributing to its antihypertensive activity. **Protein content:** Negligible at supplemental doses (micrograms); the parent sardine hydrolysate powder may contain ~80–90% protein by weight, but the isolated dipeptide is used for its pharmacological rather than nutritional protein value. **Micronutrients from parent hydrolysate:** Trace amounts of marine-derived minerals including selenium (~10–30 µg per gram of crude hydrolysate), zinc (~0.5–1.5 mg/g hydrolysate), phosphorus, and omega-3 fatty acid residues, though purified Val-Tyr preparations contain negligible mineral content. **Vitamins:** Not a significant source of vitamins; parent sardine material contains vitamin B12 (~8–12 µg/100g) and vitamin D3 (~4–8 µg/100g), but these are largely removed during peptide purification. **Bioavailability notes:** Val-Tyr dipeptide demonstrates high oral bioavailability (~70–80%) due to its small molecular size, enabling intact absorption via intestinal PepT1 (H⁺-coupled peptide transporter) without requiring further enzymatic digestion. It resists degradation by gastrointestinal proteases better than larger peptides. Peak plasma concentration is achieved within approximately 30–60 minutes post-ingestion. The dipeptide is partially hydrolyzed to free valine and tyrosine in enterocytes and plasma, but a significant fraction reaches target tissues (vascular endothelium, brain) in intact dipeptide form, which is essential for its ACE-inhibitory bioactivity. Tyrosine released from hydrolysis serves as a precursor to catecholamines (dopamine, norepinephrine) and thyroid hormones, contributing to neurotransmitter and metabolic regulation.
Preparation & Dosage
Sardine peptide supplements are available in capsule or powder form, with recommended dosages ranging from 200 mg to 1,000 mg daily. Consult a healthcare provider before use.
Synergy & Pairings
Coenzyme Q10, Omega-3 Fatty Acids, Magnesium
Safety & Interactions
Sardine peptide is generally well-tolerated with minimal reported side effects in healthy adults. Potential interactions may occur with ACE inhibitor medications (lisinopril, enalapril) due to additive hypotensive effects. Individuals with shellfish or fish allergies should exercise caution despite peptide processing. Pregnancy and lactation safety data is insufficient, warranting medical consultation before use.